Our laboratory is equipped with cutting-edge instruments and technologies to ensure accurate and timely results. Among these, the FLEXMAP 3D, representing Luminex's most advanced multiplexing platform, stands as a testament to our commitment to innovation. The LUMINEX 200 machine further enhances our capabilities, providing us with the tools we need to excel in our field.
RT-PCR (reverse transcription-polymerase chain reaction) based tests are invaluable in a molecular lab, offering precise and reliable detection of various pathogens and gene expression analysis. RT-PCR enables the identification of even minute quantities of viral RNA or specific gene transcripts. This sensitivity and specificity make it an essential tool for diagnosing infectious diseases & oncology related testing. We boast a suite of extractors, thermal cyclers and RT-PCR machines, all designed to meet the highest standards of excellence and offer a wide range of tests including Transplant Viral panel, tropical fever panel, MPN reflex panel etc.
One of our most notable assets is the BioFire System (nested multiplex PCR), a game-changer in syndromic infectious disease diagnostics. What sets BIOFIRE apart is its remarkable ability to deliver results for over 170 targets in less than an hour. This technology allows us to provide rapid, accurate diagnoses, ensuring swift and effective patient care.
Nucleic acid testing (NAT) is a molecular technique for screening blood donations to reduce the risk of transfusion transmitted infections (TTIs) in the recipients, thus providing an additional layer of blood safety. NAT technique is highly sensitive and specific for viral nucleic acids. It is based on amplification of targeted regions of viral ribonucleic acid or deoxyribonucleic acid (DNA) and detects them earlier than the other screening methods thus, narrowing the window period of transfusion transmitted infections.
Flow cytometry is a versatile technique used in biomedical research and clinical diagnostics to analyze and quantify cells and particles in a fluid suspension. It involves passing cells or particles through a laser beam, measuring their characteristics such as size, granularity, and fluorescence. We offer various tests like Flow cytometry Crossmatching (FCXM), Acute Leukemia panel, CLPD panel, CD19+ cells and CD34+ Stem cell enumeration, Lymphocyte subset analysis, CD4 assay etc.
The complement-dependent cytotoxicity crossmatch (CDC-XM), a technique that uses T and B lymphocytes to detect donor-specific antibodies (DSA) via activation of the classical pathway of complement, has been widely used for the detection of alloantibodies in transplant patients since it was introduced in the 1960s. CDC crossmatch is still considered to be the gold standard test to predict hyperacute graft rejection
ACTIMoS promises to revolutionize organ transplantation in the region, improving accessibility and ensuring timely and dignified support for patients and donors alike. We also aim to saves many hours of agonizing time for patients who previously had to travel to various other collection centers for blood sample donations for transplant related tests. Additionally, we adds dignity to organ donors’ families by eliminating long waits in cases of donations from brain-dead cadaver patients.
We take immense pride in introducing our state-of-the-art laboratory, a pioneering establishment that sets a new standard in molecular techniques. Located in the heart of Kerala, we are the very first facility of our kind in the field of transplant immunology within the entire state. Our mission is to provide a comprehensive range of transplant-related tests, seamlessly blending serology and molecular-based approaches, while delivering the highest quality results with remarkable efficiency.
Copyright © 2023 ACTIMoS. All Right Reserved. | Powered by Meridian Solutions Inc
